Live
- Is the shooting of Ram Pothineni’s ‘Double iSmart’ really stopped?
- Ways to Please Lord Hanuman for Protection and Prosperity
- Kavuri Lavanya Participates in Nomination Process of Chintalapudi Congress MLA Candidate Eliza
- Are ‘Pushpa 2’ Makers Releasing the FIRST Song from Allu Arjun's Film on THIS Date?
- Cyberabad SOT bust prohibited cotton seed racket
- Police impose traffic restrictions for Hanuman Jayanti Yatra today
- BS Maqbool's son Akhil Ahmed Conducts Election Campaign in Support of YSR Congress Party
- World book and copyright day 2024: Celebrating reading and literature
- 30 Families from Udayagiri SC Colony Join YCP in Presence of Abhinav Reddy
- YSRCP MLA Candidate Gangula Brijendra Reddy (Nani) to File Nomination on 24th
Pharma giant Pfizer to absorb Mylan
Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse.
New York: Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse.
The two companies said on Monday that they'll combine Mylan, a $10 billion company, with Pfizer's Upjohn, which sells household names from Viagra to cholesterol fighter Lipitor that have lost patent protection.
The deal, expected to close in the middle of next year, will have estimated annual revenue in excess of $19 billion with sales in more than 165 countries.
The name for the new company has yet to be determined. The two companies have worked together closely for years. Pfizer manufactures Mylan's EpiPen, an auto-injector used to halt life-threatening allergic reactions.
Mylan was heavily criticized, and its CEO Heather Bresch was brought before Congress two years ago, to answer questions about the price of the EpiPen, which had jumped five-fold to $600 for two doses.
EpiPens have been in short supply for more than a year because of quality problems and upgrades at a Pfizer factory.
Upjohn, the name of one of the companies Pfizer gobbled up during a spate of acquisitions in the 1990s and 2000s, sells off-patent and generic drugs that include the stars that drove Pfizer's growth: pain killers Celebrex and Lyrica, Norvasc for high blood pressure, Effexor for more heartburn and psychiatric drugs Xanax and Zoloft.
